Correction to: Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies

Collaborators, Affiliations

NIKE Group:
I Aini, M Albertelli, Y Alessi, B Altieri, S Antonini, L Barrea, F Birtolo, F Campolo, G Cannavale, C Cantone, S Carra, R Centello, A Cozzolino, S Molfetta, V Vito, G Fanciulli, T Feola, F Ferraù, S Gay, E Giannetta, F Grillo, E Grossrubatscher, V Guarnotta, A Salvia, A Laffi, A Lania, A Liccardi, P Malandrino, R Mazzilli, E Messina, N Mikovic, R Minotta, R Modica, G Muscogiuri, C Pandozzi, G Pugliese, G Puliani, A Ragni, M Rubino, F Russo, F Sesti, L Verde, A Veresani, C Vetrani, G Vitale, V Zamponi, I Zanata

¹ Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Messina, AOU Policlinico "Gaetano Martino" University Hospital, 98125, Messina, Italy. rmruggeri@unime.it.
² Department of Clinical Medicine and Surgery, Endocrinology Unit, University Federico II, Naples, Italy.
³ SSD Endocrine Disease and Diabetology, ASL TO3, Pinerolo, TO, Italy.
⁴ Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.
⁵ Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
⁶ Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.
⁷ Gruppo NETTARE, Policlinico Umberto I, Università Sapienza, Rome, Italy.
⁸ UNESCO Chair "Education for Health and Sustainable Development", Federico II University, Naples, Italy.

Published Erratum

R M Ruggeri et al. J Endocrinol Invest. 2023 Jan.

. 2023 Jan;46(1):203.

doi: 10.1007/s40618-022-01924-1.

NIKE Group:
I Aini, M Albertelli, Y Alessi, B Altieri, S Antonini, L Barrea, F Birtolo, F Campolo, G Cannavale, C Cantone, S Carra, R Centello, A Cozzolino, S Molfetta, V Vito, G Fanciulli, T Feola, F Ferraù, S Gay, E Giannetta, F Grillo, E Grossrubatscher, V Guarnotta, A Salvia, A Laffi, A Lania, A Liccardi, P Malandrino, R Mazzilli, E Messina, N Mikovic, R Minotta, R Modica, G Muscogiuri, C Pandozzi, G Pugliese, G Puliani, A Ragni, M Rubino, F Russo, F Sesti, L Verde, A Veresani, C Vetrani, G Vitale, V Zamponi, I Zanata

¹ Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Messina, AOU Policlinico "Gaetano Martino" University Hospital, 98125, Messina, Italy. rmruggeri@unime.it.
² Department of Clinical Medicine and Surgery, Endocrinology Unit, University Federico II, Naples, Italy.
³ SSD Endocrine Disease and Diabetology, ASL TO3, Pinerolo, TO, Italy.
⁴ Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.
⁵ Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
⁶ Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.
⁷ Gruppo NETTARE, Policlinico Umberto I, Università Sapienza, Rome, Italy.
⁸ UNESCO Chair "Education for Health and Sustainable Development", Federico II University, Naples, Italy.

No abstract available

Erratum for

Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
Ruggeri RM, Benevento E, De Cicco F, Fazzalari B, Guadagno E, Hasballa I, Tarsitano MG, Isidori AM, Colao A, Faggiano A; NIKE Group. Ruggeri RM, et al. J Endocrinol Invest. 2023 Feb;46(2):213-234. doi: 10.1007/s40618-022-01905-4. Epub 2022 Aug 30. J Endocrinol Invest. 2023. PMID: 36038743 Review.